Thomas J. LeBlanc is the 17th president of the George Washington University, the largest institution of higher education in Washington, D.C. Dr. LeBlanc leads a preeminent academic and research enterprise with 10 schools and colleges, more than 26,000 undergraduate and graduate students and thousands of faculty and staff across three campuses in the District of Columbia and the Commonwealth of Virginia.
 

Dr. LeBlanc has focused efforts on enhancing GW's student experience, research, philanthropy and constituent engagement, medical enterprise and institutional culture. The university is now building on this progress to advance GW toward its aspiration for preeminence as a comprehensive, global research university, leading it to its bicentennial and beyond.
 

Learn More About Dr. LeBlanc

"I believe higher education is the strongest force for social mobility in the United States. And being a part of it is what gets me up in the morning."

—President LeBlanc

The university served as a clinical trial site for the mRNA vaccine developed by NIH and Moderna, Inc., helping ensure the vaccine was safe and effective for a diverse population.

“Throughout this pandemic, the George Washington University has been at the forefront of fighting COVID-19,” GW President Thomas J. LeBlanc said. “Our Moderna vaccine clinical trial site is among our university’s most important contributions, and we are proud of the faculty, researchers and clinicians at the George Washington University School of Medicine and Health Sciences, GW Medical Faculty Associates and Milken Institute School of Public Health for once again using their expertise and our academic mission in service of the public good.”